EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Paeoniflorin Alleviates LPS‐Induced Inflammation and Acute Myocardial Injury by Inhibiting PI3K/Akt/ERK‐Mediated HIF‐1α and TLR4/MyD88/NF‐κB Inflammatory Signaling

Xiaowu Guo iD, Zhiguang Han iD, Jiahuan Sun iD, Shupeng Liu iD, Chuang Zhang iD, Gengrui Xu iD, Xiaodan Wang iD, Qiuhang Song iD, Hongxia Yang iD, Aiying Li iD

Mediators of Inflammation · 2025-01 · 2025 (1)

DOI: 10.1155/mi/2346163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, online erschienen am 19.11.2025. Verfasst von Xiaowu Guo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, College of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, China. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Lipopolysaccharides, Glucosides, Monoterpenes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hebei Province, Hebei University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis‐induced myocardial injury (SIMI) greatly increases the mortality rate of sepsis. Although paeoniflorin (PF) has been proven to improve survival in sepsis, the detailed mechanism of PF on SIMI remains elusive. In this study, network pharmacology revealed 90 overlapping targets between PF‐ and SIMI‐related targets. Analysis using the molecular complex detection (MCODE) method identified a significant module with scores exceeding 30, comprising the top 10 targets: Akt1, STAT3, CASP3, BCL2, TP53, PTGS2, CXCL8, TLR4, CCL2, and ICAM1. These targets are involved in tissue repair during inflammatory response, apoptosis, immunity, and lipopolysaccharide (LPS) immune receptor activity. The enriched pathways in inflammatory signaling, include NF‐κB signaling pathway, HIF‐1 signaling pathway, MAPK signaling pathway, and PI3K‐Akt signaling pathway. Molecular docking further verified the strong binding abilities of PF to PI3K, Akt1, ERK1, ERK2, HIF‐1α, TLR4, and NF‐κB. In LPS‐induced sepsis rat model, PF pretreatment inhibited PI3K/Akt/ERK‐mediated HIF‐1α and TLR4/MyD88/NF‐κB signaling, thereby reducing inflammation by decreasing the levels of tumor necrosis factor‐α (TNF‐α) and interleukin‐1β (IL‐1β) in serum and cardiac tissue. Ultimately, PF ameliorated SIMI by improving cardiac pathological and functional changes and mitigating myocardial injury markers, such as lactate dehydrogenase (LDH), CK‐MB, cTnT/TNNT2, TNNI3/cTn‐I, and aspartate aminotransferase (AST). Collectively, the PI3K/Akt/ERK‐mediated HIF‐1α and TLR4/MyD88/NF‐κB inflammation signaling appear to be the primary mechanisms through which PF exerts its beneficial effects on SIMI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoxia-Inducible Factor 1, alpha SubunitLipopolysaccharidesGlucosidesMonoterpenesInflammationAnimalsToll-Like Receptor 4Proto-Oncogene Proteins c-aktRatsPhosphatidylinositol 3-KinasesMaleNF-kappa BSignal TransductionRats, Sprague-DawleyMyeloid Differentiation Factor 88Molecular Docking SimulationSepsisGlycosides

Stichwörter der Autor:innen

PI3K/Akt/ERK-mediated HIF-1αTLR4/MyD88/NF-κB-inflammation signalingmolecular dockingnetwork pharmacologypaeoniflorin (PF)sepsis-induced myocardial injury (SIMI)

Substanzen

Toll-Like Receptor 4Hypoxia-Inducible Factor 1, alpha SubunitProto-Oncogene Proteins c-aktLipopolysaccharidesPhosphatidylinositol 3-KinasesNF-kappa BGlucosidesMonoterpenesMyeloid Differentiation Factor 88peoniflorin

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, College of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, China.
  • Department of Epidemic Febrile Disease, College of Traditional Chinese Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, China.
  • Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Shijiazhuang 050091, Hebei, China.
  • Hebei Higher Education Institute Applied Technology Research Center on TCM Development and Industrialization, Shijiazhuang 050091, Hebei, China.

ORCID-Profile: Xiaowu Guo, Zhiguang Han, Jiahuan Sun, Shupeng Liu, Chuang Zhang, Gengrui Xu, Xiaodan Wang, Qiuhang Song, Hongxia Yang, Aiying Li

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hebei Province
  • Hebei University of Chinese Medicine

Zitieren

APA

Guo, X., Han, Z., Sun, J., Liu, S., Zhang, C., Xu, G., Wang, X., Song, Q., Yang, H., & Li, A. (2025). Paeoniflorin Alleviates LPS‐Induced Inflammation and Acute Myocardial Injury by Inhibiting PI3K/Akt/ERK‐Mediated HIF‐1α and TLR4/MyD88/NF‐κB Inflammatory Signaling. Mediators of Inflammation, 2025(1). https://doi.org/10.1155/mi/2346163

Vancouver

Guo X, Han Z, Sun J, Liu S, Zhang C, Xu G, et al. Paeoniflorin Alleviates LPS‐Induced Inflammation and Acute Myocardial Injury by Inhibiting PI3K/Akt/ERK‐Mediated HIF‐1α and TLR4/MyD88/NF‐κB Inflammatory Signaling. Mediators of Inflammation. 2025;2025(1). doi:10.1155/mi/2346163

BibTeX
@article{Guo2025,
  author = {Guo, Xiaowu and Han, Zhiguang and Sun, Jiahuan and Liu, Shupeng and Zhang, Chuang and Xu, Gengrui and Wang, Xiaodan and Song, Qiuhang and Yang, Hongxia and Li, Aiying},
  title = {Paeoniflorin Alleviates LPS‐Induced Inflammation and Acute Myocardial Injury by Inhibiting PI3K/Akt/ERK‐Mediated HIF‐1α and TLR4/MyD88/NF‐κB Inflammatory Signaling},
  journal = {Mediators of Inflammation},
  year = {2025},
  volume = {2025},
  number = {1},
  doi = {10.1155/mi/2346163}
}
Kostenlos starten →